Insulet Reports Second Quarter 2017 Financial Results

Go back to Insulet Reports Second Quarter 2017 Financial Results

Insulet Corporation (PODD) PT Raised to $58 at Jefferies

August 4, 2017 8:38 AM EDT

Jefferies raised its price target on Insulet Corporation (NASDAQ: PODD) to $58.00 (from $48.00) while maintaining a Buy rating following the company's 2Q conference call.

The company provided more detail on the plans it announced on July 20 to abandon its distributor Ypsomed and go... More

Insulet (PODD) Reports In-Line Q2 EPS, FY Revenue Guidance Beats

August 3, 2017 5:45 PM EDT

Insulet (NASDAQ: PODD) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $109.8 million versus the consensus estimate of $106.17 million.

GUIDANCE:

Insulet sees Q3 2017 revenue of $112-116 million, versus the consensus of $110.4... More